Business Description
Mono Pharmacare Ltd
ISIN : INE0OIP01012
Total Employee Number:
115Compare
Compare
Traded in other countries / regions
MONOPHARMA.India IPO Date
2023-09-07Description
Mono Pharmacare Ltd distributes a broad range of pharmaceutical products across India. Its portfolio includes antibiotics, antifungal medicines, cough and cold remedies, antacids, analgesics, nutraceuticals, skincare, antiseptics, cardiac and diabetic drugs, and cosmetic items. The company operates through contract manufacturing, sourcing products from various manufacturers and supplying them to healthcare providers and pharmacies. Revenue is generated through the sales and distribution of these pharmaceutical and healthcare products in the Indian market.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 1.76 | |||||
Debt-to-EBITDA | 10.68 | |||||
Interest Coverage | 1.5 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.6 | |||||
Beneish M-Score | -2.13 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 65.7 | |||||
3-Year EBITDA Growth Rate | 83.7 | |||||
3-Year EPS without NRI Growth Rate | 118.9 | |||||
3-Year Book Growth Rate | 94 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.14 | |||||
9-Day RSI | 40.06 | |||||
14-Day RSI | 40.79 | |||||
3-1 Month Momentum % | -15.5 | |||||
6-1 Month Momentum % | 0.46 | |||||
12-1 Month Momentum % | -54.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.92 | |||||
Quick Ratio | 1.08 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 139.71 | |||||
Days Sales Outstanding | 122.69 | |||||
Days Payable | 58.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -48.45 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 8.63 | |||||
Operating Margin % | 3.66 | |||||
Net Margin % | 0.56 | |||||
EBITDA Margin % | 3.49 | |||||
FCF Margin % | 0.4 | |||||
OCF Margin % | 0.46 | |||||
ROE % | 2.64 | |||||
ROA % | 0.75 | |||||
ROIC % | 3.6 | |||||
3-Year ROIIC % | 6.51 | |||||
ROC (Joel Greenblatt) % | 6.27 | |||||
ROCE % | 9.01 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 22.83 | |||||
PE Ratio without NRI | 13.89 | |||||
PS Ratio | 0.14 | |||||
PB Ratio | 0.7 | |||||
Price-to-Tangible-Book | 0.69 | |||||
Price-to-Free-Cash-Flow | 51.47 | |||||
Price-to-Operating-Cash-Flow | 41.01 | |||||
EV-to-EBIT | 14.4 | |||||
EV-to-EBITDA | 14.04 | |||||
EV-to-Revenue | 0.49 | |||||
EV-to-FCF | 124.1 | |||||
Price-to-Graham-Number | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 0.71 | |||||
Earnings Yield (Greenblatt) % | 6.95 | |||||
FCF Yield % | 3.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mono Pharmacare Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,474.733 | ||
| EPS (TTM) (₹) | 0.46 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 65.26 | ||
| 14-Day RSI | 40.79 | ||
| 14-Day ATR (₹) | 0.199449 | ||
| 20-Day SMA (₹) | 10.78 | ||
| 12-1 Month Momentum % | -54.58 | ||
| 52-Week Range (₹) | 9.45 - 27.5 | ||
| Shares Outstanding (Mil) | 17.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mono Pharmacare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mono Pharmacare Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mono Pharmacare Ltd Frequently Asked Questions
What is Mono Pharmacare Ltd(NSE:MONOPHARMA)'s stock price today?
The current price of NSE:MONOPHARMA is ₹10.50. The 52 week high of NSE:MONOPHARMA is ₹27.50 and 52 week low is ₹9.45.
When is next earnings date of Mono Pharmacare Ltd(NSE:MONOPHARMA)?
The next earnings date of Mono Pharmacare Ltd(NSE:MONOPHARMA) is .
Does Mono Pharmacare Ltd(NSE:MONOPHARMA) pay dividends? If so, how much?
Mono Pharmacare Ltd(NSE:MONOPHARMA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Mono Pharmacare Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers